Back
Celldex Therapeutics Quote, Financials, Valuation and Earnings
Buy
51
CLDX
Celldex Therapeutics
Last Price:
39.91
Seasonality Move:
8.94%
7 Day Trial
ALL ACCESS PASS
$
7
Celldex Therapeutics Price Quote
$39.91
-0.03 (-0.65%)
(Updated: May 17, 2024 at 4:01 AM ET)
Celldex Therapeutics Key Stats
Buy
51
Celldex Therapeutics (CLDX)
is a Buy
Day range:
$39.42 - $40.26
52-week range:
$22.11 - $53.18
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
337.85
P/B ratio:
3.14%
Volume:
868.7K
Avg. volume:
579.8K
1-year change:
20.12%
Market cap:
$2.6B
Revenue:
$6.9M
EPS:
$-2.86
How Much Does Celldex Therapeutics Make?
-
How Much Are Celldex Therapeutics's Sales Annually?
CLDX Revenues are $6.9M -
How Much Profit Does Celldex Therapeutics's Make A Year?
CLDX net income is -$141.4M
Is Celldex Therapeutics Growing As A Company?
-
What Is Celldex Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.84% -
What Is Celldex Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Celldex Therapeutics Stock Price Performance
-
Did Celldex Therapeutics Stock Go Up Last Month?
Celldex Therapeutics share price went up by 3.47% last month -
Did CLDX's Share Price Rise Over The Last Year?
CLDX share price rose by 20.12% over the past 1 year
What Is Celldex Therapeutics 52-Week High & Low?
-
What Is Celldex Therapeutics’s 52-Week High Share Price?
Celldex Therapeutics has traded as high as $53.18 over the past 52 weeks -
What Is Celldex Therapeutics’s 52-Week Low Share Price?
Celldex Therapeutics has traded as low as $22.11 over the past 52 weeks
Celldex Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Celldex Therapeutics?
-
How Much Debt Does Celldex Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Celldex Therapeutics Have?
Cash and short term investments quarterly total is $823.8M -
What Is Celldex Therapeutics’s Book Value Per Share?
Book value per share is 12.72
Is Celldex Therapeutics Cash Flow Positive?
-
What Is CLDX Cash Flow From Operations?
Cash flow from operations (TTM) is -$119.4M -
What Is Celldex Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $653.9M -
What Is Celldex Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$473.6M
Celldex Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
CLDX return on invested capital is -34.58% -
What Is Celldex Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -32.36% -
What Is CLDX Return On Equity?
ROE is a measure of profitability and is -34.58%
Celldex Therapeutics Earnings Date & Stock Price
-
What Is Celldex Therapeutics's Stock Price Today?
A single share of CLDX can be purchased today for 39.94 -
What Is Celldex Therapeutics’s Stock Symbol?
Celldex Therapeutics trades on the nasdaq under the ticker symbol: CLDX -
When Is Celldex Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Celldex Therapeutics is scheduled on August 8, 2024 -
When Is CLDX's next ex-dividend date?
Celldex Therapeutics's next ex-dividend date is May 16, 2020 -
How To Buy Celldex Therapeutics Stock?
You can buy Celldex Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Celldex Therapeutics Competitors
-
Who Are Celldex Therapeutics's Competitors?
Below is a list of companies who compete with Celldex Therapeutics or are related in some way:
Celldex Therapeutics Dividend Yield
Data Unavailable
Celldex Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 16.83% |
| Revenue: | -83.87% | -80.9% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 69.00 |
| Upside from Last Price: | 72.76% |